Pharming Group NV PHAR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/13/24 EDT
9.40UNCH (UNCH)
Volume
1,259
52 week range
9.27 - 16.71
Loading...
  • Open9.59
  • Day High9.62
  • Day Low9.34
  • Prev Close9.34
  • 52 Week High16.71
  • 52 Week High Date09/21/23
  • 52 Week Low9.27
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap640.06M
  • Shares Out673.44M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-18.29

KEY STATS

  • Open9.59
  • Day High9.62
  • Day Low9.34
  • Prev Close9.34
  • 52 Week High16.71
  • 52 Week High Date09/21/23
  • 52 Week Low9.27
  • 52 Week Low Date04/18/24
  • Market Cap640.06M
  • Shares Out673.44M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-18.29

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pharming Group NV

 

Profile

MORE
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1...
Richard Peters M.D., Ph.D
Non-Executive Independent Chairman of the Board
Sijmen de Vries M.D.
Chief Executive Officer, Executive Director
Mireille Sanders
Chief Operations Officer
Jeroen Wakkerman
Chief Financial Officer
Address
Darwinweg 24
Leiden
2333 CR
Netherlands